Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

THEO-24

THEOPHYLLINE

Standard Dose
400MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview THEO-24 is listed in Drugs@FDA under application 087943 (ANDA).

Marketing status: Prescription Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 400MG Sponsor ENDO OPERATIONS Submission history Latest submission status date: 2005-03-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview THEO-24 is listed in Drugs@FDA under application 087943 (ANDA). Marketing status: Prescription Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 400MG Sponsor ENDO OPERATIONS Submission history Latest submission status date: 2005-03-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.